PLACIDI, FABIO
 Distribuzione geografica
Continente #
NA - Nord America 36.793
EU - Europa 2.607
AS - Asia 778
SA - Sud America 21
Continente sconosciuto - Info sul continente non disponibili 11
OC - Oceania 11
AF - Africa 3
Totale 40.224
Nazione #
US - Stati Uniti d'America 36.757
UA - Ucraina 487
IE - Irlanda 444
DE - Germania 414
CN - Cina 381
IT - Italia 363
KR - Corea 200
GB - Regno Unito 195
FR - Francia 154
SE - Svezia 126
RU - Federazione Russa 119
FI - Finlandia 108
SG - Singapore 106
PL - Polonia 101
CA - Canada 29
CZ - Repubblica Ceca 27
BE - Belgio 18
JP - Giappone 18
NL - Olanda 16
IN - India 14
BR - Brasile 12
EU - Europa 10
KG - Kirghizistan 10
AU - Australia 8
VN - Vietnam 8
ES - Italia 7
HK - Hong Kong 6
IL - Israele 6
CH - Svizzera 5
MX - Messico 5
DK - Danimarca 4
HU - Ungheria 4
ID - Indonesia 4
AR - Argentina 3
AT - Austria 3
GR - Grecia 3
NZ - Nuova Zelanda 3
PE - Perù 3
AM - Armenia 2
BD - Bangladesh 2
CL - Cile 2
EG - Egitto 2
IR - Iran 2
KZ - Kazakistan 2
LK - Sri Lanka 2
PH - Filippine 2
PT - Portogallo 2
RO - Romania 2
TH - Thailandia 2
TW - Taiwan 2
UZ - Uzbekistan 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AE - Emirati Arabi Uniti 1
BG - Bulgaria 1
CR - Costa Rica 1
DM - Dominica 1
EC - Ecuador 1
IQ - Iraq 1
KW - Kuwait 1
LV - Lettonia 1
MD - Moldavia 1
MY - Malesia 1
NO - Norvegia 1
NP - Nepal 1
SA - Arabia Saudita 1
SI - Slovenia 1
TN - Tunisia 1
TR - Turchia 1
Totale 40.224
Città #
Woodbridge 10.741
Wilmington 10.081
Houston 8.860
Fairfield 1.375
Ann Arbor 806
Chandler 663
Ashburn 646
Seattle 569
Cambridge 476
Jacksonville 411
Dublin 407
Medford 309
Beijing 202
Dearborn 178
New York 176
Lawrence 145
Rome 126
Kraków 94
San Diego 89
Menlo Park 82
Moscow 62
Singapore 62
Zhengzhou 58
Norwalk 44
Mülheim 41
Boardman 40
Milan 33
Redwood City 30
London 29
Palo Alto 25
Brno 23
Shanghai 20
Verona 20
Brussels 18
Mountain View 18
Toronto 17
Daejeon 16
Seoul 16
Washington 16
University Park 15
Falls Church 13
Hefei 13
Kilburn 13
Phoenix 13
Helsinki 11
Pune 11
San Mateo 11
Hangzhou 10
Nanjing 10
Guangzhou 9
Los Angeles 9
São Paulo 9
Florence 8
Jinan 8
Nuremberg 8
Redmond 8
San Francisco 8
Dong Ket 7
Kunming 7
Philadelphia 7
Creede 6
Hounslow 6
Munich 6
Victoria 6
Amsterdam 5
Durham 5
Fuzhou 5
Hebei 5
Naples 5
Tokyo 5
Auburn Hills 4
Budapest 4
Chicago 4
Council Bluffs 4
Huskvarna 4
Indiana 4
Lappeenranta 4
Nanchang 4
Roebling 4
Sacramento 4
San Jose 4
Athens 3
Atlanta 3
Bari 3
Bologna 3
Colorado Springs 3
Columbus 3
Detroit 3
Islington 3
Lima 3
Madrid 3
Nashville 3
New Bedfont 3
Nürnberg 3
Palermo 3
Pisa 3
Solofra 3
Southwark 3
Sutton Coldfield 3
Turin 3
Totale 37.387
Nome #
Chronic dopaminergic treatment in restless legs syndrome: Does it affect the autonomic nervous system? 446
Obstructive sleep apnoea as a risk factor for osteopenia and osteoporosis in the male population: further data and comments 446
Development of collateral veins as a favorable prognostic factor for complete recovery in cerebral venous thrombosis due to Tribulus terrestris 445
Predicting seizures in untreated temporal lobe epilepsy using point-process nonlinear models of heartbeat dynamics 435
Cerebrospinal fluid levels of the endocannabinoid anandamide are reduced in patients with untreated newly diagnosed temporal lobe epilepsy. 433
Increasing cortical excitability: A possible explanation for the proconvulsant role of sleep deprivation 429
Multicenter case-control study on restless legs syndrome in multiple sclerosis: The REMS Study 426
Effective treatment of narcolepsy-cataplexy with duloxetine: a report of three cases. 425
Cognitive and psychiatric effects of topiramate monotherapy in migraine treatment: an open study. 425
Continuous positive airway pressure treatment increases serum vitamin D levels in male patients with obstructive sleep apnea 422
Unexpected total recovery in a patient with post-anoxic complete alpha coma predicted by recording of cortical SEPs 421
Unexpected total recovery in a patient with post-anoxic complete alpha coma predicted by recording of cortical SEPs 420
Bilateral frontal polymicrogyria and epilepsy in a patient with Turner mosaicism: a case report 414
Cerebral hemodynamic changes in sleep apnea syndrome and effect of continuous positive airway pressure treatment 413
Topiramate: effect on EEG interictal abnormalities and background activity in patients affected by focal epilepsy. 412
Unilateral spatial neglect and alien limb phenomenon may be early features of Creutzfeldt-Jakob disease 407
Pure ictal sensory seizures may represent a clinical manifestation of PLEDs 406
Temporal lobe epileptic activity mimicking dementia: a case report 405
Symptomatic nonconvulsive status epilepticus erroneously suggestive of sporadic Creutzfeldt-Jakob disease 402
Effective treatment of nocturnal frontal lobe epilepsy with lacosamide: a report of two cases 402
Oxcarbazepine in Nocturnal Frontal-Lobe Epilepsy: A Further Interesting Report 401
Optic Nerve dysfunction in obstructive sleep apnea: An electrophysiological study 401
Cerebrovascular reactivity and subcortical infarctions 400
Nocturnal sleep and daytime somnolence in untreated patients with temporal lobe epilepsy: changes after treatment with controlled-release carbamazepine 398
Gabapentin as add-on therapy in focal epilepsy: a computerized EEG study 397
Sleep disorders in spinal and bulbar muscular atrophy (Kennedy's disease): a controlled polysomnographic and self-reported questionnaires study. 397
Ketotic hyperglycemia and epilepsia partialis continua 395
Dynamic susceptibility contrast (DSC) MRI and interictal epileptiform activity in cryptogenic partial epilepsy 394
Effect of cabergoline added to levodopa treatment on sleep-wake cycle in idiopathic Parkinson's disease: an open label 24-hour polysomnographic study 394
Restless legs syndrome and poliomyelitis: New evidences of an old observation? 394
Coma, alterazioni della coscienza e sonno 393
Estrogen deficiency hampers the beneficial effect of continuous positive airway pressure therapy on serum vitamin D concentrations in postmenopausal women affected by obstructive sleep apnea 393
Baroreflex Buffering of Sympathetic Activation during Sleep: Evidence from Autonomic Assessment of Sleep Macroarchitecture and Microarchitecture 391
Sleep disorders in myotonic dystrophy type 2: a controlled polysomnographic study and self-reported questionnaires 387
Fronto-central monomorphic theta activity as EEG pattern of ictal psychosis 387
Effects of zonisamide as add-on therapy on sleep-wake cycle in focal epilepsy: a polysomnographic study 386
Rapid eye movement sleep disruption and sleep fragmentation are associated with increased orexin-A cerebrospinal-fluid levels in mild cognitive impairment due to Alzheimer's disease 386
Physical activity contradictorily affects bone mineral density in obstructive sleep apnea patients at different ages 385
Panic disorder or epilepsy? A case report 384
Bilateral thalamic stroke due to nasal ephedrine and naphazoline use 384
Changes of the EEG paroxysmal pattern during felbamate therapy in Lennox-Gastaut syndrome: a case report. 383
Orexinergic system dysregulation, sleep impairment, and cognitive decline in Alzheimer disease 381
Pedunculopontine nucleus stimulation influences REM sleep in Parkinson's disease 377
Effects of epilepsy treatment on sleep architecture and daytime sleepiness: an evidence-based review of objective sleep metrics 375
Sleep-wake cycle and effects of cabergoline monotherapy in de novo Parkinson's disease patients - An ambulatory polysomnographic study 374
Panic attacks as ictal manifestation of a meningioma of the left anterior clinoid [Attacchi di panico come manifestazioni critiche di un meningioma della clinoide anteriore sinistra] 374
Obstructive sleep apnoea as a risk factor for osteopenia and osteoporosis in the male population 373
Spastic paraplegia, epilepsy, and mental retardation in several members of a family: a novel genetic disorder 371
Gabapentin-induced modulation of interictal epileptiform activity related to different vigilance levels 370
Revised diagnostic criteria for the pseudotumor cerebri syndrome in adults and children. 368
Cerebrospinal-fluid orexin levels and daytime somnolence in frontotemporal dementia 367
Restless legs syndrome and daytime sleepiness are prominent in myotonic dystrophy type 2 364
Changes in nocturnal sleep and day time somnolence after CBZ administration [MODIFICAZIONI DEL SONNO NOTTURNO E DELLA SONNOLENZA DIURNA DOPO SOMMINISTRAZIONE DI CARBAMAZEPINA] 363
Rotigotine effect on sleep in a de novo Parkinson's Disease patient affected by periodic limb movement disorder 361
Sleep disorders in spinal and bulbar muscular atrophy (Kennedy's disease): a controlled polysomnographic and self-reported questionnaires study 359
Impairment of daytime cerebrovascular reactivity in patients with obstructive sleep apnoea syndrome 358
Sleep in healthy elderly subjects: A 24-hour ambulatory polysomnographic study 355
Topiramate-induced restless legs syndrome: A report of two cases [3] 355
Beta-amyloid and phosphorylated tau metabolism changes in narcolepsy over time 354
Spasticity as an ictal pattern due to excitotoxic upper motor neuron damage 353
Is autonomic nervous system involved in restless legs syndrome during wakefulness? 349
Cognitive profile and brain morphological changes in obstructive sleep apnea 345
Folic acid supplements during pregnancy in specific clinical settings: What dowe know about epilepsy? 342
Multiple sleep latency test may be not sensitive in obstructive sleep apnea with comorbid narcolepsy revealed by low cerebrospinal fluid orexin levels 341
Bilateral hemispheric activation in the early recovery of motor function after stroke 340
Lacosamide as add-on treatment of focal symptomatic epilepsy in a patient with alcoholic liver cirrhosis 338
Is autonomic nervous system involved in restless legs syndrome during wakefulness? 338
Electroencephalography and dementia: a literature review and future perspectives 337
Does continuous positive airway pressure treatment affect autonomic nervous system in patients with severe obstructive sleep apnea? 337
Sleep abnormalities in mentally retarded autistic subjects: Down's syndrome with mental retardation and normal subjects 336
Increased cortical excitability after selective REM sleep deprivation in healthy humans: a transcranial magnetic stimulation study 335
MicroRNA expression is dysregulated in narcolepsy: A new evidence? 335
Effects of adjunctive perampanel on sleep quality, daytime somnolence and cognition in refractory focal epilepsy: Further data 335
Multiple idiosyncratic adverse effects of antiepileptic drugs in a patient with partial trisomy of chromosome 9 and epilepsy [Reazioni idiosincrasiche multiple a farmaci antiepilettici in una paziente con trisomia parziale del cromosoma 9 ed epilessia] 334
A 23 years follow-up study identifies GLUT1 deficiency syndrome initially diagnosed as complicated hereditary spastic paraplegia 334
CSF beta-amyloid levels are altered in narcolepsy: a link with the inflammatory hypothesis? 333
Rotigotine may improve sleep architecture in Parkinson's disease: a double-blind, randomized, placebo-controlled polysomnographic study. 331
Effect of antiepileptic drugs on sleep 326
May CSF beta-amyloid and tau proteins levels be influenced by long treatment duration and stable medication in narcolepsy? 326
Nocturnal frontal lobe epilepsy with paroxysmal arousals due to CHRNA2 loss of function 322
Paucisymptomatic Marchiafava-Bignami disease with relevant diffusion-weighted MRI lesions 322
Sleep disorders in adult-onset myotonic dystrophy type 1: a controlled polysomnographic study 320
L-dopa-induced excessive daytime sleepiness in PD: a placebo-controlled case with MSLT assessment. 316
Pregabalin as add-on therapy induces REM sleep enhancement in partial epilepsy: A polysomnographic study 315
Ictal aphasia as manifestation of partial status epilepticus in a long-lasting misdiagnosed symptomatic epilepsy: An emblematic case 313
Obstructive sleep apnoea and bone health 313
Non-motor functions in parkinsonian patients implanted in the pedunculopontine nucleus: focus on sleep and cognitive domains. 309
Case report: subependymal diffuse heterotopia. Clinical, EEG, and neuroimaging findings 308
Cerebral glucose metabolism in idiopathic REM sleep behavior disorder is different from tau-related and α-synuclein-related neurodegenerative disorders: A brain [18F]FDG PET study 308
Sleep episodes and daytime somnolence as result of individual susceptibility to different dopaminergic drugs in a PD patient: a polysomnographic study 300
Daytime autonomic activity in idiopathic rapid eye movement sleep behavior disorder: a preliminary study 297
Restless legs syndrome and post polio syndrome: a case-control study 293
Circadian variation of fatigue in paralytic poliomyelitis and postpolio syndrome: just fatigue or masked restless legs syndrome? 287
Pedunculopontine nucleus stimulation influences REM sleep in Parkinson's disease 283
Sleep-wake cycle in the Kennedy's disease: a controlled polysomnographic study and self-reported questionnaires 277
Clinical case report: multiple idiosyncratic adverse effects of antiepileptic drugs in trisomy 9p 275
Continuous positive airway pressure treatment may improve optic nerve function in obstructive sleep apnea: An electrophysiological study 259
Evaluation of patients with focal epilepsy in the intercritical phase with perfusion mr imaging and eeg 249
Sleep apnoeas may represent a reversible risk factor for amyloid-β pathology 241
Comparative Sleep Disturbances in Myotonic Dystrophy Types 1 and 2 236
Totale 36.151
Categoria #
all - tutte 80.265
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 80.265


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/202011.316 922 800 764 1.011 884 1.125 880 1.168 1.095 997 792 878
2020/20216.691 798 857 693 836 715 719 785 623 142 207 235 81
2021/20221.539 78 97 71 33 49 121 115 46 86 131 72 640
2022/20231.920 227 131 58 231 179 432 174 119 165 38 104 62
2023/2024796 116 23 36 40 69 242 31 57 13 24 17 128
2024/2025112 112 0 0 0 0 0 0 0 0 0 0 0
Totale 40.668